Početna › Rak pluća › Illinois
Kliničke studije za Rak pluća u državi Illinois
62 studija za Rak pluća traži sudionike na lokacijama u državi Illinois.
Gradovi u državi Illinois
- Chicago41 studija
- Evanston19 studija
- Cicero17 studija
- Waukegan16 studija
- Naperville13 studija
- Joliet12 studija
- Peoria12 studija
- Springfield12 studija
- Aurora11 studija
- Decatur10 studija
- Bloomington9 studija
- Danville9 studija
- Champaign9 studija
- Galesburg9 studija
- Arlington Heights9 studija
- North Peoria9 studija
- Charleston8 studija
- Elgin8 studija
- Rockford5 studija
- Carbondale4 studija
Službeni tekst studije (engleski)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Rush-Copley Medical Center, Aurora
- Advocate Good Shepherd Hospital, Barrington
- Illinois CancerCare-Bloomington, Bloomington
- i još 42
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04267848Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- i još 54
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
- University of Illinois Hospital & Health Sciences System ( Site 0044), Chicago
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07286149A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- University of Illinois Cancer Center, Chicago
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06172478Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- Advocate Good Shepherd Hospital, Barrington
- i još 25
U tijeku regrutacijaFaza 3
Od 70 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06096844Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Rush-Copley Medical Center, Aurora
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- i još 35
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT04181060Empathic Communication Skills (ECS) Training
- Advocate Health Care Network, Libertyville
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 100 godina · Oba spola · Ažurirano 1. lis 2026. · NCT05456841Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Northwestern University, Chicago
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb
- Northwestern Medicine Cancer Center Delnor, Geneva
- i još 7
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06498635Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- University of Illinois Cancer Center, Chicago
- Center for Care and Discovery, Chicago
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT06881784Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- Hope and Healing Clinical Research, Hinsdale
- Hope and Healing Clinical Research, New Lenox
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07476287A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- North Shore University Health System ( Site 4014), Evanston
- Accellacare of Duly ( Site 4005), Lisle
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06312137Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Illinois CancerCare - Bloomington, Bloomington
- University of Illinois Hospital and Health Sciences System (Outpatient Cancer Center), Chicago
- University of Illinois Hospital and Health Sciences System, Chicago
- i još 10
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07222566A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- University of Illinois Chicago, Chicago
- Illinois Cancer Specialists, Niles
U tijeku regrutacijaFaza 3
Od 18 do 100 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT05920356Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Hope and Healing Clinical Research, Hinsdale
- Hope and Healing Clinical Research, New Lenox
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07489066This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Endeavor Health, Elmhurst
- Hope and Healing Cancer Services, Hinsdale
- Advocate Medical Group - Libertyville Oncology, Libertyville
- i još 4
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06758401A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Rush University Medical Center, Chicago
- University of Illinois Chicago, Chicago
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07154290A Registry for People With Lung Cancer
- Rush University Medical Center (Data collection only), Chicago
- Endeavor Health, Evanston
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06424327A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Local Institution - 0605, Decatur
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07063745Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Research Site, Chicago
U tijeku regrutacijaFaza 2
Od 18 do 95 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT05061550Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- Rush University Medical Center, Chicago
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07100080Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- University of Chicago Comprehensive Cancer Center, Chicago
- UC Comprehensive Cancer Center at Silver Cross, New Lenox
- University of Chicago Medicine-Orland Park, Orland Park
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT06287775Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- University of Illinois Cancer Center, Chicago
- University of Chicago Medicine, Chicago
- City of Hope - Chicago, Zion
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 10. ruj 2026. · NCT06293898A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Affiliated Oncologists, LLC, Chicago Ridge
- City of Hope® Cancer Center Chicago, Zion
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06793215A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Illinois at Chicago, Chicago
- University of Chicago Hospital, Chicago
- Springfield Clinic Main Campus, Springfield
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06119581A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
- University of Chicago, New Lenox
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06561685Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- OSF Saint Francis Medical Center, Peoria
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06343402Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- Illinois Cancer Specialists, Arlington Heights
- University of Illinois Hospital and Health Sciences Systems, Chicago
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT07185997Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Illinois Cancer Specialists, Niles
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT06712355Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- Alton Memorial Hospital, Alton
- Northwestern University, Chicago
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb
- i još 3
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT06500481Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- Advocate Good Shepherd Hospital, Barrington
- i još 46
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT05624996Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- St. Francis Medical Center (OSF Healthcare), Peoria
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT07444814Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Chicago
- Xencor Investigative Site, Chicago
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 3. kol 2026. · NCT05433142Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- Captain James A. Lovell Federal Health Care Center, North Chicago
U tijeku regrutacija
Od 50 do 80 godina · Oba spola · Ažurirano 16. srp 2026. · NCT07168993CARE Tool Study Aim 3
- Alton Memorial Hospital, Alton
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 8. srp 2026. · NCT07296887Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Advocate Aurora Health, Park Ridge
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 26. lip 2026. · NCT04614103A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer
- o University of Chicago Medicine Comprehensive Cancer Center, Chicago
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 16. lip 2026. · NCT07603856Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Advocate Good Shepherd Hospital, Barrington
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- i još 47
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 3. lip 2026. · NCT05642572Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
- Northwestern University, Chicago
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 29. svi 2026. · NCT05802186A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- University of Chicago, Chicago
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 27. svi 2026. · NCT03093116Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.